Answers are grounded in this paper and cite their sources.
Construction of HAP-1 peptide-engineered liposomal leonurine (HAP-Lipo@Leo) for efficient treatment of rheumatoid arthritis by downregulating inflammation, halting migration and invasion of activated FLS, and preserving cartilage/bone integrity.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: